ALDH1+ cell subpopulations enriched for cancer-initiating activity can be readily identified by flow cytometry using the Aldefluor® reagent, which quantifies ALDH activity by measuring the conversion of the ALDH substrate BODIPY aminoacetaldehyde to the fluorescent product BODIPY aminoacetate. Here, LDHA is linked to cancer.